Rodrigo Bagur, MD, PhD, FAHA
Dr. Bagur received his MD degree in 2000 from the National University of Cordoba, Cordoba, Argentina, where he also completed postgraduate Internal Medicine training in 2004, and a Cardiology fellowship in 2008. Subsequently, he completed a 3-year fellowship in Interventional Cardiology at the Quebec Heart & Lung Institute, Laval University, in 2011. During his fellowship, he received full training in transradial coronary interventions and he is one of the first interventional cardiologists to receive formal training in transcatheter aortic valve implantation (TAVI) in Canada.
Dr. Bagur has a strong commitment to clinical research and received his PhD in Experimental Medicine at Laval University in Quebec City. His PhD thesis focused on cardiovascular outcomes after TAVI and he successfully finished this in 2012.
Prior to his appointment to the London Health Sciences Centre (LHSC), Dr. Bagur had an academic appointment as Assistant Clinical Professor of Medicine, Department of Medicine, at Laval University, and served as an Interventional Cardiologist at the Quebec University Hospital Centre in Quebec City during 2012-2014. At the beginning of 2015 he moved to London, Ontario, where he was appointed as a staff Interventional Cardiologist in the Division of Cardiology, LHSC, and Assistant Clinical Professor, Department of Medicine, Western University.
Dr. Bagur's special interests are catheter-based cardiovascular interventions, including transradial coronary and saphenous vein graft interventions, chronic total occlusion recanalization and transcatheter aortic valve implantation. He is also focused on aortic stenosis, low-flow and low-gradient aortic stenosis, cardiovascular outcomes and postgraduate medical education and fellowship training.
Dr. Bagur is a Fellow of the American Heart Association (FAHA) and a Member of the Canadian Association of Interventional Cardiology (CAIC), European Society of Cardiology (ESC), European Association of Percutaneous Cardiovascular Interventions (EAPCI), and Working Group on Valvular Heart Disease of the ESC.